25 XP   0   0   10

Procter & Gamble Health Limited
Buy, Hold or Sell?

Let's analyse Procter & Gamble Health Limited together

PenkeI guess you are interested in Procter & Gamble Health Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Procter & Gamble Health Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Procter & Gamble Health Limited

I send you an email if I find something interesting about Procter & Gamble Health Limited.

Quick analysis of Procter & Gamble Health Limited (30 sec.)










What can you expect buying and holding a share of Procter & Gamble Health Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR2.71
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR452.36
Expected worth in 1 year
INR776.23
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR549.88
Return On Investment
11.6%

For what price can you sell your share?

Current Price per Share
INR4,729.20
Expected price per share
INR4,627 - INR5,186
How sure are you?
50%

1. Valuation of Procter & Gamble Health Limited (5 min.)




Live pricePrice per Share (EOD)

INR4,729.20

Intrinsic Value Per Share

INR-275.18 - INR1,809.68

Total Value Per Share

INR177.18 - INR2,262.04

2. Growth of Procter & Gamble Health Limited (5 min.)




Is Procter & Gamble Health Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$90.1m$73.9m$16.1m17.9%

How much money is Procter & Gamble Health Limited making?

Current yearPrevious yearGrowGrow %
Making money$27.5m$23.1m$4.4m16.1%
Net Profit Margin18.7%17.6%--

How much money comes from the company's main activities?

3. Financial Health of Procter & Gamble Health Limited (5 min.)




What can you expect buying and holding a share of Procter & Gamble Health Limited? (5 min.)

Welcome investor! Procter & Gamble Health Limited's management wants to use your money to grow the business. In return you get a share of Procter & Gamble Health Limited.

What can you expect buying and holding a share of Procter & Gamble Health Limited?

First you should know what it really means to hold a share of Procter & Gamble Health Limited. And how you can make/lose money.

Speculation

The Price per Share of Procter & Gamble Health Limited is INR4,729. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Procter & Gamble Health Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Procter & Gamble Health Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR452.36. Based on the TTM, the Book Value Change Per Share is INR80.97 per quarter. Based on the YOY, the Book Value Change Per Share is INR-52.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR56.50 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Procter & Gamble Health Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps1.660.0%1.660.0%1.390.0%2.320.0%1.390.0%
Usd Book Value Change Per Share0.970.0%0.970.0%-0.630.0%0.030.0%0.190.0%
Usd Dividend Per Share0.680.0%0.680.0%2.050.0%2.410.1%1.250.0%
Usd Total Gains Per Share1.650.0%1.650.0%1.420.0%2.440.1%1.440.0%
Usd Price Per Share47.44-47.44-64.06-56.53-33.57-
Price to Earnings Ratio28.60-28.60-46.03-37.68-30.35-
Price-to-Total Gains Ratio28.76-28.76-45.07-34.43-29.51-
Price to Book Ratio8.74-8.74-14.37-10.10-6.23-
Price-to-Total Gains Ratio28.76-28.76-45.07-34.43-29.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share56.7504
Number of shares17
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.682.41
Usd Book Value Change Per Share0.970.03
Usd Total Gains Per Share1.652.44
Gains per Quarter (17 shares)28.0441.42
Gains per Year (17 shares)112.17165.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
146661021642156
2921322143283322
31381983264925488
41842644386567654
52313305508209820
627739666298410986
73234627741148121152
83695298861312141318
94155959981476161484
1046166111101640171650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%12.04.00.075.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.00.02.087.5%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%

Fundamentals of Procter & Gamble Health Limited

About Procter & Gamble Health Limited

Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.

Fundamental data was last updated by Penke on 2024-04-09 11:33:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Procter & Gamble Health Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Procter & Gamble Health Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Procter & Gamble Health Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 18.7% means that ₹0.19 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Procter & Gamble Health Limited:

  • The MRQ is 18.7%. The company is making a huge profit. +2
  • The TTM is 18.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.7%TTM18.7%0.0%
TTM18.7%YOY17.6%+1.0%
TTM18.7%5Y34.3%-15.7%
5Y34.3%10Y20.6%+13.8%
1.1.2. Return on Assets

Shows how efficient Procter & Gamble Health Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Procter & Gamble Health Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 20.8% Return on Assets means that Procter & Gamble Health Limited generated ₹0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Procter & Gamble Health Limited:

  • The MRQ is 20.8%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 20.8%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ20.8%TTM20.8%0.0%
TTM20.8%YOY21.5%-0.7%
TTM20.8%5Y24.5%-3.6%
5Y24.5%10Y16.2%+8.3%
1.1.3. Return on Equity

Shows how efficient Procter & Gamble Health Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Procter & Gamble Health Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 30.6% Return on Equity means Procter & Gamble Health Limited generated ₹0.31 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Procter & Gamble Health Limited:

  • The MRQ is 30.6%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 30.6%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ30.6%TTM30.6%0.0%
TTM30.6%YOY31.2%-0.7%
TTM30.6%5Y32.0%-1.5%
5Y32.0%10Y21.2%+10.8%

1.2. Operating Efficiency of Procter & Gamble Health Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Procter & Gamble Health Limited is operating .

  • Measures how much profit Procter & Gamble Health Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Procter & Gamble Health Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 25.6% means the company generated ₹0.26  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Procter & Gamble Health Limited:

  • The MRQ is 25.6%. The company is operating very efficient. +2
  • The TTM is 25.6%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ25.6%TTM25.6%0.0%
TTM25.6%YOY23.8%+1.7%
TTM25.6%5Y23.0%+2.5%
5Y23.0%10Y17.1%+5.9%
1.2.2. Operating Ratio

Measures how efficient Procter & Gamble Health Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.76 means that the operating costs are ₹0.76 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Procter & Gamble Health Limited:

  • The MRQ is 0.759. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.759. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.759TTM0.7590.000
TTM0.759YOY0.729+0.031
TTM0.7595Y0.768-0.008
5Y0.76810Y0.834-0.066

1.3. Liquidity of Procter & Gamble Health Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Procter & Gamble Health Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.62 means the company has ₹2.62 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Procter & Gamble Health Limited:

  • The MRQ is 2.620. The company is able to pay all its short-term debts. +1
  • The TTM is 2.620. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.620TTM2.6200.000
TTM2.620YOY2.602+0.018
TTM2.6205Y4.060-1.440
5Y4.06010Y3.811+0.249
1.3.2. Quick Ratio

Measures if Procter & Gamble Health Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Procter & Gamble Health Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.93 means the company can pay off ₹1.93 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Procter & Gamble Health Limited:

  • The MRQ is 1.934. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.934. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.934TTM1.9340.000
TTM1.934YOY1.850+0.084
TTM1.9345Y3.145-1.211
5Y3.14510Y2.646+0.499

1.4. Solvency of Procter & Gamble Health Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Procter & Gamble Health Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Procter & Gamble Health Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.32 means that Procter & Gamble Health Limited assets are financed with 31.8% credit (debt) and the remaining percentage (100% - 31.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Procter & Gamble Health Limited:

  • The MRQ is 0.318. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.318. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.318TTM0.3180.000
TTM0.318YOY0.310+0.008
TTM0.3185Y0.254+0.064
5Y0.25410Y0.245+0.008
1.4.2. Debt to Equity Ratio

Measures if Procter & Gamble Health Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Procter & Gamble Health Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 46.7% means that company has ₹0.47 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Procter & Gamble Health Limited:

  • The MRQ is 0.467. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.467. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.467TTM0.4670.000
TTM0.467YOY0.450+0.017
TTM0.4675Y0.352+0.115
5Y0.35210Y0.332+0.020

2. Market Valuation of Procter & Gamble Health Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Procter & Gamble Health Limited generates.

  • Above 15 is considered overpriced but always compare Procter & Gamble Health Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 28.60 means the investor is paying ₹28.60 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Procter & Gamble Health Limited:

  • The EOD is 34.210. Based on the earnings, the company is overpriced. -1
  • The MRQ is 28.595. Based on the earnings, the company is overpriced. -1
  • The TTM is 28.595. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD34.210MRQ28.595+5.615
MRQ28.595TTM28.5950.000
TTM28.595YOY46.029-17.433
TTM28.5955Y37.682-9.087
5Y37.68210Y30.346+7.336
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Procter & Gamble Health Limited:

  • The EOD is 40.565. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 33.907. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 33.907. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD40.565MRQ33.907+6.658
MRQ33.907TTM33.9070.000
TTM33.907YOY67.336-33.429
TTM33.9075Y30.685+3.222
5Y30.68510Y23.505+7.180
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Procter & Gamble Health Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 8.74 means the investor is paying ₹8.74 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Procter & Gamble Health Limited:

  • The EOD is 10.455. Based on the equity, the company is expensive. -2
  • The MRQ is 8.739. Based on the equity, the company is overpriced. -1
  • The TTM is 8.739. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD10.455MRQ8.739+1.716
MRQ8.739TTM8.7390.000
TTM8.739YOY14.374-5.635
TTM8.7395Y10.102-1.363
5Y10.10210Y6.234+3.868
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Procter & Gamble Health Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--80.96780.9670%-52.544+165%2.124+3712%16.099+403%
Book Value Per Share--452.360452.3600%371.393+22%544.302-17%455.748-1%
Current Ratio--2.6202.6200%2.602+1%4.060-35%3.811-31%
Debt To Asset Ratio--0.3180.3180%0.310+3%0.254+25%0.245+30%
Debt To Equity Ratio--0.4670.4670%0.450+4%0.352+33%0.332+40%
Dividend Per Share--56.50256.5020%171.000-67%200.939-72%104.024-46%
Eps--138.240138.2400%115.980+19%193.191-28%116.217+19%
Free Cash Flow Per Share--116.583116.5830%79.280+47%76.552+52%42.423+175%
Free Cash Flow To Equity Per Share--57.26157.2610%-94.600+265%-126.731+321%-63.455+211%
Gross Profit Margin--1.0001.0000%0.431+132%0.624+60%0.488+105%
Intrinsic Value_10Y_max--1809.680--------
Intrinsic Value_10Y_min---275.178--------
Intrinsic Value_1Y_max--121.246--------
Intrinsic Value_1Y_min--25.029--------
Intrinsic Value_3Y_max--410.096--------
Intrinsic Value_3Y_min--30.086--------
Intrinsic Value_5Y_max--754.166--------
Intrinsic Value_5Y_min---14.341--------
Market Cap78501882480.000+16%65617428200.00065617428200.0000%88614236960.000-26%78197449484.000-16%46439643398.000+41%
Net Profit Margin--0.1870.1870%0.176+6%0.343-46%0.206-9%
Operating Margin--0.2560.2560%0.238+7%0.230+11%0.171+49%
Operating Ratio--0.7590.7590%0.729+4%0.768-1%0.834-9%
Pb Ratio10.455+16%8.7398.7390%14.374-39%10.102-13%6.234+40%
Pe Ratio34.210+16%28.59528.5950%46.029-38%37.682-24%30.346-6%
Price Per Share4729.200+16%3953.0003953.0000%5338.400-26%4710.860-16%2797.670+41%
Price To Free Cash Flow Ratio40.565+16%33.90733.9070%67.336-50%30.685+10%23.505+44%
Price To Total Gains Ratio34.402+16%28.75628.7560%45.066-36%34.434-16%29.511-3%
Quick Ratio--1.9341.9340%1.850+5%3.145-39%2.646-27%
Return On Assets--0.2080.2080%0.215-3%0.245-15%0.162+29%
Return On Equity--0.3060.3060%0.312-2%0.320-5%0.212+44%
Total Gains Per Share--137.469137.4690%118.456+16%203.063-32%120.123+14%
Usd Book Value--90106800.00090106800.0000%73978800.000+22%108420960.000-17%90781680.000-1%
Usd Book Value Change Per Share--0.9720.9720%-0.631+165%0.025+3712%0.193+403%
Usd Book Value Per Share--5.4285.4280%4.457+22%6.532-17%5.469-1%
Usd Dividend Per Share--0.6780.6780%2.052-67%2.411-72%1.248-46%
Usd Eps--1.6591.6590%1.392+19%2.318-28%1.395+19%
Usd Free Cash Flow--23222400.00023222400.0000%15792000.000+47%15248640.000+52%8450280.000+175%
Usd Free Cash Flow Per Share--1.3991.3990%0.951+47%0.919+52%0.509+175%
Usd Free Cash Flow To Equity Per Share--0.6870.6870%-1.135+265%-1.521+321%-0.761+211%
Usd Market Cap942022589.760+16%787409138.400787409138.4000%1063370843.520-26%938369393.808-16%557275720.776+41%
Usd Price Per Share56.750+16%47.43647.4360%64.061-26%56.530-16%33.572+41%
Usd Profit--27536400.00027536400.0000%23102400.000+19%38565540.326-29%23152290.163+19%
Usd Revenue--147554400.000147554400.0000%131044800.000+13%121555788.406+21%117193374.203+26%
Usd Total Gains Per Share--1.6501.6500%1.421+16%2.437-32%1.441+14%
 EOD+4 -4MRQTTM+0 -0YOY+25 -115Y+14 -2210Y+22 -14

3.2. Fundamental Score

Let's check the fundamental score of Procter & Gamble Health Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1534.210
Price to Book Ratio (EOD)Between0-110.455
Net Profit Margin (MRQ)Greater than00.187
Operating Margin (MRQ)Greater than00.256
Quick Ratio (MRQ)Greater than11.934
Current Ratio (MRQ)Greater than12.620
Debt to Asset Ratio (MRQ)Less than10.318
Debt to Equity Ratio (MRQ)Less than10.467
Return on Equity (MRQ)Greater than0.150.306
Return on Assets (MRQ)Greater than0.050.208
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Procter & Gamble Health Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.360
Ma 20Greater thanMa 504,755.988
Ma 50Greater thanMa 1004,952.993
Ma 100Greater thanMa 2004,954.195
OpenGreater thanClose4,750.050
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets11,011,900
Total Liabilities3,503,000
Total Stockholder Equity7,508,900
 As reported
Total Liabilities 3,503,000
Total Stockholder Equity+ 7,508,900
Total Assets = 11,011,900

Assets

Total Assets11,011,900
Total Current Assets7,961,000
Long-term Assets3,050,900
Total Current Assets
Cash And Cash Equivalents 4,350,500
Short-term Investments 177,300
Net Receivables 1,172,400
Inventory 1,349,400
Other Current Assets 911,400
Total Current Assets  (as reported)7,961,000
Total Current Assets  (calculated)7,961,000
+/-0
Long-term Assets
Property Plant Equipment 1,732,700
Intangible Assets 9,400
Long-term Assets Other 1,182,000
Long-term Assets  (as reported)3,050,900
Long-term Assets  (calculated)2,924,100
+/- 126,800

Liabilities & Shareholders' Equity

Total Current Liabilities3,039,000
Long-term Liabilities464,000
Total Stockholder Equity7,508,900
Total Current Liabilities
Short-term Debt 31,200
Accounts payable 2,370,400
Other Current Liabilities 89,200
Total Current Liabilities  (as reported)3,039,000
Total Current Liabilities  (calculated)2,490,800
+/- 548,200
Long-term Liabilities
Long term Debt Total 88,800
Other Liabilities 375,200
Long-term Liabilities  (as reported)464,000
Long-term Liabilities  (calculated)464,000
+/-0
Total Stockholder Equity
Common Stock166,000
Retained Earnings 3,709,100
Accumulated Other Comprehensive Income 3,519,900
Capital Surplus 111,300
Total Stockholder Equity (as reported)7,508,900
Total Stockholder Equity (calculated)7,506,300
+/- 2,600
Other
Capital Stock166,000
Cash And Equivalents3,396,300
Cash and Short Term Investments 4,527,800
Common Stock Shares Outstanding 16,599
Current Deferred Revenue548,200
Liabilities and Stockholders Equity 11,011,900
Net Debt -4,230,500
Net Invested Capital 7,508,900
Net Tangible Assets 7,499,500
Net Working Capital 4,922,000
Property Plant and Equipment Gross 1,732,700
Short Long Term Debt Total 120,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
4,895,300
5,605,300
5,681,600
4,299,800
4,996,200
5,942,700
6,486,100
7,082,200
7,839,700
8,828,300
9,912,200
17,594,600
11,763,800
9,861,600
8,937,200
11,011,900
11,011,9008,937,2009,861,60011,763,80017,594,6009,912,2008,828,3007,839,7007,082,2006,486,1005,942,7004,996,2004,299,8005,681,6005,605,3004,895,300
   > Total Current Assets 
2,150,600
3,453,900
4,803,100
3,551,000
4,043,600
4,584,900
4,780,700
4,986,400
5,724,100
6,409,500
7,523,300
15,343,000
9,561,900
7,271,400
6,136,400
7,961,000
7,961,0006,136,4007,271,4009,561,90015,343,0007,523,3006,409,5005,724,1004,986,4004,780,7004,584,9004,043,6003,551,0004,803,1003,453,9002,150,600
       Cash And Cash Equivalents 
1,169,100
1,847,700
3,246,400
1,427,700
1,132,800
1,929,800
1,876,900
1,639,500
1,884,200
2,792,700
2,777,400
12,429,000
6,390,900
4,640,500
3,194,000
4,350,500
4,350,5003,194,0004,640,5006,390,90012,429,0002,777,4002,792,7001,884,2001,639,5001,876,9001,929,8001,132,8001,427,7003,246,4001,847,7001,169,100
       Short-term Investments 
0
0
0
0
0
236,400
242,900
238,700
422,800
277,800
699,700
-851,400
51,480
108,400
125,900
177,300
177,300125,900108,40051,480-851,400699,700277,800422,800238,700242,900236,40000000
       Net Receivables 
0
0
0
0
0
0
0
0
1,212,400
1,070,400
1,602,400
929,200
999,400
717,200
1,043,600
1,172,400
1,172,4001,043,600717,200999,400929,2001,602,4001,070,4001,212,40000000000
       Inventory 
362,900
729,800
584,900
611,200
1,130,900
1,309,600
1,518,200
1,773,200
1,668,600
1,658,900
1,577,400
1,133,500
1,360,000
1,183,700
1,152,100
1,349,400
1,349,4001,152,1001,183,7001,360,0001,133,5001,577,4001,658,9001,668,6001,773,2001,518,2001,309,6001,130,900611,200584,900729,800362,900
       Other Current Assets 
618,600
876,400
971,800
1,512,100
1,779,900
1,109,100
1,142,700
1,335,000
1,748,500
1,680,100
866,400
851,300
811,600
730,000
746,700
911,400
911,400746,700730,000811,600851,300866,4001,680,1001,748,5001,335,0001,142,7001,109,1001,779,9001,512,100971,800876,400618,600
   > Long-term Assets 
2,744,700
2,151,400
878,500
748,800
952,600
1,357,800
1,705,400
2,095,800
2,115,600
2,418,800
2,388,900
2,251,600
2,201,900
2,590,200
2,800,800
3,050,900
3,050,9002,800,8002,590,2002,201,9002,251,6002,388,9002,418,8002,115,6002,095,8001,705,4001,357,800952,600748,800878,5002,151,4002,744,700
       Property Plant Equipment 
405,000
622,100
640,300
512,400
725,200
767,700
937,900
1,371,500
1,385,900
1,404,700
1,265,000
1,176,700
1,194,200
1,401,300
1,496,200
1,732,700
1,732,7001,496,2001,401,3001,194,2001,176,7001,265,0001,404,7001,385,9001,371,500937,900767,700725,200512,400640,300622,100405,000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
81,130
0
0
0
00081,130000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
1,400
1,700
7,900
4,300
2,100
1,200
400
9,400
9,4004001,2002,1004,3007,9001,7001,40000000000
       Long-term Assets Other 
2,339,700
1,529,300
238,200
201,800
227,400
590,100
767,500
702,600
672,900
840,700
1,421,600
-100
814,000
1,015,200
1,146,000
1,182,000
1,182,0001,146,0001,015,200814,000-1001,421,600840,700672,900702,600767,500590,100227,400201,800238,2001,529,3002,339,700
> Total Liabilities 
666,300
1,091,400
1,008,700
835,600
895,400
1,106,100
1,255,800
1,539,200
1,924,200
2,373,700
2,579,600
2,193,500
2,700,400
2,824,500
2,772,300
3,503,000
3,503,0002,772,3002,824,5002,700,4002,193,5002,579,6002,373,7001,924,2001,539,2001,255,8001,106,100895,400835,6001,008,7001,091,400666,300
   > Total Current Liabilities 
618,300
1,067,600
987,500
835,600
887,000
970,700
1,123,200
1,352,100
1,658,600
2,084,100
2,252,600
1,960,200
2,273,400
2,389,700
2,358,300
3,039,000
3,039,0002,358,3002,389,7002,273,4001,960,2002,252,6002,084,1001,658,6001,352,1001,123,200970,700887,000835,600987,5001,067,600618,300
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
67,100
65,300
79,000
47,500
28,300
31,200
31,20028,30047,50079,00065,30067,1000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
67,100
65,300
0
0
0
0
000065,30067,1000000000000
       Accounts payable 
0
0
0
0
0
408,600
368,100
437,700
655,500
751,100
832,800
914,200
1,239,600
1,287,600
1,760,100
2,370,400
2,370,4001,760,1001,287,6001,239,600914,200832,800751,100655,500437,700368,100408,60000000
       Other Current Liabilities 
618,300
1,067,600
987,500
835,600
887,000
562,100
755,100
914,400
1,003,100
1,333,000
1,352,700
980,700
943,800
82,400
564,300
89,200
89,200564,30082,400943,800980,7001,352,7001,333,0001,003,100914,400755,100562,100887,000835,600987,5001,067,600618,300
   > Long-term Liabilities 
48,000
23,800
21,200
0
8,400
135,400
132,600
187,100
265,600
289,600
327,000
233,300
427,000
434,800
414,000
464,000
464,000414,000434,800427,000233,300327,000289,600265,600187,100132,600135,4008,400021,20023,80048,000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
28,600
0
88,800
88,800028,6000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
271,200
289,600
327,000
265,400
420,600
406,200
414,000
375,200
375,200414,000406,200420,600265,400327,000289,600271,20000000000
> Total Stockholder Equity
4,229,000
4,513,900
4,672,900
3,464,200
4,100,800
4,836,600
5,230,300
5,543,000
5,915,500
6,454,600
7,332,600
15,401,100
9,063,400
7,037,100
6,164,900
7,508,900
7,508,9006,164,9007,037,1009,063,40015,401,1007,332,6006,454,6005,915,5005,543,0005,230,3004,836,6004,100,8003,464,2004,672,9004,513,9004,229,000
   Common Stock
168,600
168,600
166,000
166,000
166,000
166,000
166,000
166,000
166,000
166,000
166,000
166,000
166,000
166,000
166,000
166,000
166,000166,000166,000166,000166,000166,000166,000166,000166,000166,000166,000166,000166,000166,000168,600168,600
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 
-787,800
-801,300
-854,700
-1,043,300
-964,400
0
-991,300
-1,089,000
-1,263,100
-1,548,500
-759,600
-853,600
3,463,500
3,482,800
3,514,300
3,519,900
3,519,9003,514,3003,482,8003,463,500-853,600-759,600-1,548,500-1,263,100-1,089,000-991,3000-964,400-1,043,300-854,700-801,300-787,800
   Capital Surplus 
0
0
0
0
0
0
0
0
111,300
111,300
111,300
111,300
111,300
111,300
111,300
111,300
111,300111,300111,300111,300111,300111,300111,300111,30000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
4,848,200
5,146,600
5,361,600
4,341,500
4,899,200
3,340,100
991,300
4,528,200
4,742,600
5,103,900
4,315,000
4,409,000
111,300
111,300
113,900
113,900
113,900113,900111,300111,3004,409,0004,315,0005,103,9004,742,6004,528,200991,3003,340,1004,899,2004,341,5005,361,6005,146,6004,848,200



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue12,370,000
Cost of Revenue-3,624,900
Gross Profit8,745,1008,745,100
 
Operating Income (+$)
Gross Profit8,745,100
Operating Expense-9,423,100
Operating Income2,946,900-678,000
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense9,423,1000
 
Net Interest Income (+$)
Interest Income-
Interest Expense-7,900
Other Finance Cost-0
Net Interest Income-7,900
 
Pretax Income (+$)
Operating Income2,946,900
Net Interest Income-7,900
Other Non-Operating Income Expenses-
Income Before Tax (EBT)3,156,5002,946,900
EBIT - interestExpense = -7,900
2,313,800
2,321,700
Interest Expense7,900
Earnings Before Interest and Taxes (EBIT)-3,164,400
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax3,156,500
Tax Provision-842,700
Net Income From Continuing Ops2,313,8002,313,800
Net Income2,313,800
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-7,900
 

Technical Analysis of Procter & Gamble Health Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Procter & Gamble Health Limited. The general trend of Procter & Gamble Health Limited is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Procter & Gamble Health Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Procter & Gamble Health Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4,840 < 5,010 < 5,186.

The bearish price targets are: 4,675 > 4,655 > 4,627.

Tweet this
Procter & Gamble Health Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Procter & Gamble Health Limited. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Procter & Gamble Health Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Procter & Gamble Health Limited. The current macd is -60.60394272.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Procter & Gamble Health Limited price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Procter & Gamble Health Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Procter & Gamble Health Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Procter & Gamble Health Limited Daily Moving Average Convergence/Divergence (MACD) ChartProcter & Gamble Health Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Procter & Gamble Health Limited. The current adx is 39.02.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Procter & Gamble Health Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Procter & Gamble Health Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Procter & Gamble Health Limited. The current sar is 4,646.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Procter & Gamble Health Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Procter & Gamble Health Limited. The current rsi is 40.36. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Procter & Gamble Health Limited Daily Relative Strength Index (RSI) ChartProcter & Gamble Health Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Procter & Gamble Health Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Procter & Gamble Health Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Procter & Gamble Health Limited Daily Stochastic Oscillator ChartProcter & Gamble Health Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Procter & Gamble Health Limited. The current cci is -45.9189076.

Procter & Gamble Health Limited Daily Commodity Channel Index (CCI) ChartProcter & Gamble Health Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Procter & Gamble Health Limited. The current cmo is -14.8793668.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Procter & Gamble Health Limited Daily Chande Momentum Oscillator (CMO) ChartProcter & Gamble Health Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Procter & Gamble Health Limited. The current willr is -56.09323537.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Procter & Gamble Health Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Procter & Gamble Health Limited Daily Williams %R ChartProcter & Gamble Health Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Procter & Gamble Health Limited.

Procter & Gamble Health Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Procter & Gamble Health Limited. The current atr is 84.69.

Procter & Gamble Health Limited Daily Average True Range (ATR) ChartProcter & Gamble Health Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Procter & Gamble Health Limited. The current obv is 299,015.

Procter & Gamble Health Limited Daily On-Balance Volume (OBV) ChartProcter & Gamble Health Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Procter & Gamble Health Limited. The current mfi is 39.16.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Procter & Gamble Health Limited Daily Money Flow Index (MFI) ChartProcter & Gamble Health Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Procter & Gamble Health Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Procter & Gamble Health Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Procter & Gamble Health Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.360
Ma 20Greater thanMa 504,755.988
Ma 50Greater thanMa 1004,952.993
Ma 100Greater thanMa 2004,954.195
OpenGreater thanClose4,750.050
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Procter & Gamble Health Limited with someone you think should read this too:
  • Are you bullish or bearish on Procter & Gamble Health Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Procter & Gamble Health Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Procter & Gamble Health Limited

I send you an email if I find something interesting about Procter & Gamble Health Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Procter & Gamble Health Limited.

Receive notifications about Procter & Gamble Health Limited in your mailbox!